The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
Abstract
Thrombin activatable fibrinolysis inhibitor (TAFI, or procarboxypeptidase B) is the precursor of a recently described carboxypeptidase that potently attenuates fibrinolysis. Therefore, we hypothesized that elevated plasma TAFI levels induce a hypofibrinolytic state associated with an increased risk for venous thrombosis. To evaluate this hypothesis, we developed an electroimmunoassay for TAFI antigen and used this assay to measure TAFI levels in the Leiden Thrombophilia Study, a case–control study of venous thrombosis in 474 patients with a first deep vein thrombosis and 474 age- and sex-matched control subjects. In 474 healthy control subjects, an increase of TAFI with age was observed in women but not in men. Oral contraceptive use also increased the TAFI concentration. TAFI levels above the 90th percentile of the controls (> 122 U/dL) increased the risk for thrombosis nearly 2-fold compared with TAFI levels below the 90th percentile (odds ratio, 1.7; 95% confidence interval, 1.1-2.5). Adjustment for various possible confounders did not materially affect this estimate. These results indicate that elevated TAFI levels form a mild risk factor for venous thrombosis. Such levels were found in 9% of healthy controls and in 14% of patients with a first deep vein thrombosis. Elevated TAFI levels did not enhance the thrombotic risk associated with factor V Leiden but may interact with high factor VIII levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationPurification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
Bajzar, L., Manuel, R., & Nesheim, M. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14477 · Cited by 680
Bajzar, L., Morser, J., & Nesheim, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16603 · Cited by 644
Eaton, D. L., Malloy, B. E., Tsai, S. P., Henzel, W., & Drayna, D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54713-x · Cited by 382
Juhan-Vague, I., Valadier, J., Alessi, M. C., Aillaud, M. F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., & Collen, D. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651064 · Cited by 362
Nilsson, I. M., Ljungnér, H., & Tengborn, L. (1985) · BMJ · doi:10.1136/bmj.290.6480.1453 · Cited by 336
van Hinsbergh, V., Bertina, R., van Wijngaarden, A., van Tilburg, N., Emeis, J., & Haverkate, F. (1985) · Blood · doi:10.1182/blood.v65.2.444.444 · Cited by 302
Self-citationThe Leiden Thrombophilia Study (LETS)
Meer, F. J. M. V. D., Koster, T., Vandenbroucke, J. P., Briët, E., & Rosendaal, F. R. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657602 · Cited by 275
Self-citationOral contraceptives and venous thromboembolism: findings in a large prospective study.
Vessey, M., Mant, D., Smith, A., & Yeates, D. (1986) · BMJ · doi:10.1136/bmj.292.6519.526 · Cited by 259
Cited by
Fibrinolysis and the control of blood coagulation
Chapin, J. C., & Hajjar, K. A. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.09.003 · Cited by 839
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Self-citationHematologic manifestations of celiac disease
Halfdanarson, T. R., Litzow, M. R., & Murray, J. A. (2007) · Blood · doi:10.1182/blood-2006-07-031104 · Cited by 380
Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-267740 · Cited by 364
Self-citationRisk Factors in Venous Thromboembolism
Martinelli, I. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616237 · Cited by 291
Metadata
- Authors
- van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-05-01
- Volume
- 95
- Issue
- 9
- Pages
- 2855-2859
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2133640678
- Cited by
- 373
- References
- 18
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. https://app.cochat.ai/papers/10.1182/blood.v95.9.2855.009k02_2855_2859
- The paper
- van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000). Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood. https://doi.org/10.1182/blood.v95.9.2855.009k02_2855_2859
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.